The device was not included as a potential treatment despite sham-controlled evidence showing it reduces patient symptoms.

In the ‘80s, researchers set out to test a medication called sildenafil citrate for treating high blood pressure and angina ...

Objective: To assess the clinical efficacy, safety and effects on quality of life of trimetazidine modified release (MR) in patients with stable angina. Methods: This large, open-label ...

Calcium antagonists are used in the treatment of hypertension and angina. In the mid-1990s there was considerable debate concerning the safety of calcium antagonists in the treatment of ...

Medically reviewed by Michael Menna, DO Left arm pain can come on suddenly or be felt for a long time. Anytime someone has ...

The risk of both heartburn and cardiovascular issues increases with age. Here's how to tell them apart and what you can do.

XyloCor Therapeutics, Inc., ("XyloCor"), a clinical stage biopharmaceutical company developing novel gene therapies for cardiovascular disease, today announced the completion of a $67.5 million Series ...

Vitiligo, a skin condition causing depigmentation, may significantly increase the risk of serious cardiovascular events.

Physicians aware of the poor accuracy of non-invasive tests, often wrongly dismiss CMD as a cause of symptoms while conversely, if microvascular angina is presumed without verification, empirical ...

As we continue to understand its benefits, Terminalia Arjuna remains a fascinating study area and a promising natural remedy ...

During his Jan. 8 general audience, Pope Francis enjoyed a circus performance that included two animatronic elephants, evoking Pope Leo X’s pet elephant.

Hengdian Group Capital (HgC) and Apeloa Pharmaceutical (subsidiaries of Hengdian Group) will attend the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco from January 13-16, 2025.